Verified against court and regulatory records · No upfront fees · Your information is never sold
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Free · Confidential · About 2 minutes · A case specialist responds within 1 business day
Your answers are never sold or shared without your consent.
Key FDA Recalls and Safety Communications
The Composix Kugel Mesh Patch recall (2005-2007) was the first major hernia mesh recall, issued after reports of memory recoil ring failure causing intestinal perforations and fistulas. The FDA classified multiple Kugel recall actions as Class I — the most serious classification, indicating that use of the product may cause serious injury or death. Approximately 100,000 to 200,000 units were recalled across multiple lot numbers over the two-year recall period.
In October 2008, the FDA issued a Public Health Notification warning that it had received over 1,000 adverse event reports from nine manufacturers of surgical mesh used for hernia repair over a three-year period. Complications reported included mesh erosion, infection, pain, and recurrence. The FDA advised surgeons and patients to carefully weigh risks and benefits and to discuss mesh type options before surgery.
In 2016, the FDA issued 522 post-market surveillance study orders to hernia mesh manufacturers requiring them to conduct rigorous clinical studies examining long-term complication rates, particularly mesh shrinkage and chronic pain. The 522 orders acknowledge the FDA's concerns that pre-market data submitted through the 510(k) clearance process was insufficient to characterize long-term mesh performance. The 510(k) clearance pathway — which cleared most hernia mesh by demonstrating substantial equivalence to older devices rather than through independent clinical trials — is itself the subject of criticism in the litigation.
What the Recall History Means for Legal Claims
The documented FDA recall history and safety communications are significant in litigation because they demonstrate that the regulatory agency — and by extension the manufacturers who reported adverse events that triggered these actions — had knowledge of mesh complication patterns. This regulatory record supports plaintiff theories that manufacturers had sufficient notice to revise product warnings, update labeling, or alter mesh design, and that their failure to do so constitutes actionable negligence, design defect, or fraud.
Key data
Data & Statistics
2005–2007
FDA MedWatch recall database
1,000+
FDA Public Health Notification (October 2008)
2016
FDA 522 Order Database
FAQ
Frequently Asked Questions
Dive deeper
Related Guides
- Davol and C.R. Bard Hernia Mesh ProductsDavol Inc. and its parent C.R. Bard (now Becton Dickinson) manufactured the largest portfolio of recalled and litigation-linked hernia mesh products in the United States. Products including 3DMax, Ventralex ST, and the recalled Composix Kugel are at the center of MDL 2846 — one of the largest active medical device MDLs in federal court.
- Hernia Mesh Infection ClaimsHernia mesh infection is a devastating complication because bacteria colonize the mesh material in treatment-resistant biofilms, usually requiring complete surgical removal. Mesh design characteristics — including pore size, material composition, and surface coatings — directly affect infection susceptibility, creating strong product liability theories.
- Hernia Mesh Settlements — What to ExpectHernia mesh mass tort settlements are structured as tiered grids based on injury severity, number of revision surgeries, and individual case factors. Understanding how settlement grids work and what factors increase your tier placement helps you evaluate your claim and avoid accepting inadequate offers.
- Hernia Mesh Evidence — Building Your ClaimA strong hernia mesh claim rests on three evidentiary pillars: confirmed product identification (which specific mesh was implanted), documented complications in medical records, and expert opinions causally linking the mesh to the injuries. Gathering and preserving this evidence from the moment complications are identified is the single most important step a potential claimant can take.
- Ethicon and Johnson and Johnson Hernia MeshEthicon, a Johnson and Johnson subsidiary, manufactured the Physiomesh Flexible Composite — voluntarily withdrawn from global markets in May 2016 after independent registry data revealed reoperation rates two to three times higher than comparator meshes. Ethicon Physiomesh and related product claims are consolidated in MDL 2753 in the District of New Jersey and MCL 616 in New Jersey Superior Court.
- Hernia Mesh Complications — What Can Go WrongDefective hernia mesh can cause a spectrum of complications from painful but treatable infections to catastrophic bowel perforation and sepsis. Understanding which complications are associated with mesh defects — versus routine surgical risks — is essential for evaluating whether a legal claim exists.
- Hernia Mesh Revision Surgery — What It InvolvesHernia mesh revision surgery — including adhesiolysis, partial mesh removal, and complete explantation — is a significantly more complex and dangerous operation than the original hernia repair. The risks, costs, and recovery demands of revision surgery are core elements of damages in hernia mesh litigation.
- Inguinal Hernia Mesh ClaimsInguinal hernia mesh repairs are the most common hernia surgery in the United States, accounting for approximately 800,000 procedures annually. The inguinal region's proximity to critical nerves and spermatic cord structures makes mesh complications in this location particularly likely to cause chronic, debilitating pain.
- Ventral Hernia Mesh ClaimsVentral hernias — including incisional hernias following prior abdominal surgeries — are typically repaired with large sheets of synthetic mesh placed intra-abdominally or in the retromuscular space. The large surface area of ventral mesh in contact with bowel creates significant risk of adhesion, migration, and bowel obstruction.
- Hernia Mesh MDL 2846 — What You Need to KnowMDL 2846 in the Southern District of Ohio is the federal coordination for all Davol/C.R. Bard hernia mesh cases. With over 20,000 cases and ongoing bellwether trials, understanding how the MDL works is essential for any potential claimant navigating this litigation.
- Hernia Mesh Chronic Pain — Inguinodynia ClaimsChronic groin pain (inguinodynia) following hernia mesh repair affects an estimated 10 to 30 percent of patients in some surgical registry studies and is the most common basis for hernia mesh legal claims. Nerve entrapment by mesh fixation devices and mesh contracture are the primary mechanisms. Chronic pain claims are legally cognizable even without revision surgery.
The full investigation